Long Term Survivor
Showing 1 - 25 of >10,000
Cancer Survivor, Prostate Carcinoma Trial in Duarte (Educational Intervention, Laboratory Biomarker Analysis, Long-term
Active, not recruiting
- Cancer Survivor
- Prostate Carcinoma
- Educational Intervention
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 31, 2023
Gefitinib Long-term Survivor Study
Terminated
- EGFR Mutation Positive Advanced Non-small-cell Lung Cancer
-
Beijing, Beijing, China
- +13 more
Mar 9, 2022
SARS-CoV-2 Acute Respiratory Disease Trial in Taipei
Recruiting
- SARS-CoV-2 Acute Respiratory Disease
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 29, 2022
RWE on mPDAC Long-term Survival After Treatment With Liposomal
Recruiting
- Pancreatic Cancer Metastatic
-
Munich, GermanyKlinikum der Universität München, - Anstalt des öffentlichen Rec
Nov 24, 2023
Hypertension, Blood Pressure Trial in Kladno (Long-term non-invasive Blood pressure monitoring)
Enrolling by invitation
- Hypertension
- Blood Pressure
- Long-term non-invasive Blood pressure monitoring
-
Kladno, CzechiaCzech Technical University in Prague
Oct 18, 2023
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Recruiting
- Cushing Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Long-Term Post Thrombotic Syndrome Assessment.
Recruiting
- Post Thrombotic Syndrome
- Phone call
-
Grenoble, FranceROLLAND
Sep 19, 2023
Epilepsy Trial (UNEEG EpiSight solution)
Not yet recruiting
- Epilepsy
- UNEEG EpiSight solution
- (no location specified)
Jun 22, 2023
After Removal of Rib Stabilization Hardware in Blunt Chest
Not yet recruiting
- Rib Fractures
- data collection on patient reported long-term outcome of SSRF hardware removal
-
Basel, SwitzerlandDepartment of Thoracic Surgery, University Hospital Basel
Aug 14, 2023
Bioprothetic Valve Versus Mechanical Valve of Bioprothetic Valve
Recruiting
- Long-term Outcomes of Bioprothetic Valve Versus Mechanical Valve
- valve
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 11, 2023
Long Term Survivors of Ovarian Cancer
Active, not recruiting
- Ovarian Cancer
- Questionnaire
- Interview
-
West Hollywood, California
- +4 more
Aug 22, 2022
Childhood Cancer, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in San Francisco (Survivorship mobile
Recruiting
- Childhood Cancer
- +2 more
- Survivorship mobile application
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 1, 2023
Laryngectomy; Status Trial in São Paulo (Provox Life)
Not yet recruiting
- Laryngectomy; Status
- Provox Life
-
São Paulo, BrazilInstituto de Cancer Dr. Arnaldo
Oct 10, 2023
End Stage Kidney Disease Trial in Huntley (Alio platform)
Recruiting
- End Stage Kidney Disease
- Alio platform
-
Huntley, IllinoisSite 1
Sep 21, 2023
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
Enrolling by invitation
- Kidney Transplant Rejection
- End Stage Renal Disease
- Urine sample
- +2 more
-
Leuven, Belgium
- +5 more
Aug 3, 2023
Long-term Effects of Cancer Treatment, Long-term Effects Secondary to Cancer Therapy in Adults Trial (CUMACA-M Program)
Not yet recruiting
- Long-term Effects of Cancer Treatment
- Long-term Effects Secondary to Cancer Therapy in Adults
- CUMACA-M Program
- (no location specified)
Apr 7, 2022
(LTFU) of Patients Treated With Genome-edited Autologous
Not yet recruiting
- Sickle Cell Disease
- OTQ923
- (no location specified)
Nov 24, 2023
Assessment of Long-term Effects of Tachosil
Completed
- Fibrin Sealant
- Haemostasis
- TachoSil®
- (no location specified)
Aug 2, 2023
Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Short course radiotherapy with concurrent capecitabine(825mg/m2)
- Long course radiotherapy with concurrent capecitabine(825mg/m2)
- (no location specified)
Jun 24, 2023
Chronic Non-Cancer Pain: Risks and Benefits
Enrolling by invitation
- Chronic Non-Cancer Pain
- Opioid Use Disorder
-
Uppsala, SwedenUppsala Univeristy Hospital
Sep 25, 2023
Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in
Not yet recruiting
- Knee Osteoarthritis
- (no location specified)
Aug 28, 2023
Elderly, Cancer Surgery, Dexmedetomidine Trial in Beijing, Xi'an, Shanghai (Dexmedetomidine, Placebo)
Recruiting
- Elderly
- +3 more
- Dexmedetomidine
- Placebo
-
Beijing, Beijing, China, China
- +2 more
Sep 14, 2023
Long Term Efficacy and Safety Trial (Imlifidase administered in the 20-HMedIdeS-19 (PAES) study, Best available treatment
Not yet recruiting
- Long Term Efficacy and Safety
- Imlifidase administered in the 20-HMedIdeS-19 (PAES) study
- Best available treatment administered in the 20-HMedIdeS-19 (PAES) study
- (no location specified)
Jun 30, 2023
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of
Recruiting
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- 6-month course of antiandrogen drugs
- Long-term course of antiandrogen drugs
-
Nanjing, Jiangsu, ChinaUrology dpt, First Affiliated Hospital of Nanjing Medical Univer
Jul 13, 2023
Patient With Anti-GABAbr Antibodies Associated-encephalitis.
Completed
- Autoimmune Encephalitis
- Long-term outcome
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 14, 2023